# K122502: Bridge Extracellular Collegen Matrix

- Pathway: 510(k) (Traditional)
- Applicant: Harbor Medtech, Inc.
- Decided: Feb 26, 2013 after 194 days
- Product code: KGN (Wound Dressing With Animal-Derived Material(S))
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K881854 (1988). 13 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 15 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K071425: Unite Biomatrix, Pegasus Biologics, Inc. (2007) Summary page 2.
- K061711: Oasis Wound Matrix, Cook Biotech, Inc. (2006) Summary page 2.

## Most influential descendants
- K140367: Architect PX Extracellular Collagen Matrix (2014), 0 descendants of its own

## Indications for use
The Harbor MedTech BriDGE Extracellular Collagen Matrix Wound Dressing is indicated for the local management of moderately to heavy exuding wounds, including: * Partial and full thickness wounds, * Draining wounds, * Pressure sores/ulcers, * Venous ulcers, * Chronic vascular ulcers, * Diabetic ulcers, * Trauma wounds (e.g., abrasions, lacerations, partial thickness bums, skin tears), * Surgical wounds (e.g., donor sites/grafts, post-laser surgery, post-Mohs surgery, podiatric wounds, dlehisced surgical incisions)

Source page: https://510kreport.com/device/K122502
Methodology: https://510kreport.com/methodology
